28 Dec 2011 07:00
28 December 2011
Phorm, Inc. ("Phorm" or the "Company")
Director Dealing
Phorm (AIM: PHRM and PHRX) announces that on December 28th Kent Ertugrul, CEO and Chairman of the Company, transferred for nil consideration 2,594,412 shares in the Company to Value Trust Holdings Pte Ltd limited for tax planning purposes.
For Enquiries
Phorm, Inc.
Andy Croxson (analysts & investors) +44 20 7297 2326
Alex Laity (media) +44 20 7297 2710
Canaccord Genuity Limited +44 20 7050 6500
(Nominated Advisor)
Simon Bridges, Andrew Chubb